The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow May 7, 2019 In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first
Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the Workshop Director for the upcoming Bio-TracⓇ Symposium, “Laser Microdissection: From
New Lab Space Designed to Attract Biotech Talent and Community Opens at 704 Quince Orchard
Baltimore Biotech Earns International Recognition for Advanced Development and Manufacturing Facility December 19, 2018 Located
Image Credit: www.utunisphere.com October 1, 2018 The Unisphere Opens in Silver Spring to Grow Transplantable
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors GERMANTOWN, Md., July 18, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq:
Immunomic Therapeutics Appoints Andrew Eisen, M.D., Ph.D. As VP, Clinical Development ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held,
